(Addendum: Another way of looking at this is that the WH envisions a βminimum premiumβ requirement that goes far beyond just requiring all enrollees to pay a de minimis premium. Either way, the incipient WH proposal is much stingier than meets the eye.)
26.11.2025 20:36 β π 1 π 0 π¬ 0 π 0
But, before even getting there, itβs important to recognize that whatβs been called a WH proposal to extend the enhanced subsidies actually falls well short of a full extension. /end
26.11.2025 20:36 β π 0 π 0 π¬ 1 π 0
To gauge the proposalβs overall impact, one would also need to consider the proposalβs cuts to the underlying subsidy structure (i.e., the new $5 minimum premium & ending silver loading), the new HSA proposal, and the various regulatory and other changes.
26.11.2025 20:36 β π 0 π 0 π¬ 1 π 0
While thereβs been a lot of attention to the fact that the White House was going to propose not extending the enhanced credits above 700% of the FPL, these changes below 200% of the FPL would be far more consequential, both in coverage and fiscal impact.
26.11.2025 20:36 β π 0 π 0 π¬ 1 π 0
In 2025, people below 133% of the FPL accounted for about a quarter of enrollment (> 6 million people), and the 133-200% of FPL group accounted for close to two-fifths of enrollment (~9 million people). All told, about 2/3 of Marketplace enrollees have incomes below 200% of FPL.
26.11.2025 20:36 β π 0 π 0 π¬ 1 π 0
That change would wipe out almost all of the benefit of the enhanced credits for people with incomes below 133% of the FPL and much of the benefit for people in the 133-200% of FPL range (about two-thirds right at 133% of the FPL, falling gradually to zero at 200% of FPL).
26.11.2025 20:36 β π 0 π 0 π¬ 1 π 0
Press accounts suggest that, under the incipient WH proposal, all of these applicable percentages would go up to at least 2%. (The phrasing here is a little bit unclear, but this seems like the most sensible interpretation of whatβs written.)
apnews.com/article/trum...
26.11.2025 20:36 β π 0 π 0 π¬ 1 π 0
What Congress did in the ARP/IRA was lower these applicable percentages (and newly create one for people at or above 400% of the FPL). This is what makes the βenhancedβ subsidies βenhanced.β See the enhanced & underlying schedules below.
26.11.2025 20:36 β π 0 π 0 π¬ 1 π 0
Some background: the generosity of the premium tax credit is controlled by βapplicable percentagesβ set in law, which determine the percentage of income that a subsidy recipient is expected to contribute to a benchmark plan. They vary based on income.
26.11.2025 20:36 β π 0 π 0 π¬ 1 π 0
Thereβs a feature of the abortive White House ACA subsidy proposal that I think has been underappreciated. Namely, it seems to only partially extend the enhanced subsidies for people with incomes below 200% of the FPL (~$31k for a single person). Thatβs about 2/3 of enrollees.
26.11.2025 20:36 β π 5 π 3 π¬ 1 π 0
Addendum: Ack. This tweet had crucial typo. The 2nd sentence should be "Enrollees who shift from TM to MA when MA grows are likely *cheaper* than the average TM enrollee but *costlier* than the average MA enrollee, so *both* groups likely get more costly as MA grows."
bsky.app/profile/matt...
10.10.2025 14:08 β π 0 π 0 π¬ 0 π 0
Ack. This tweet had a crucial typo. The second sentence should read "Enrollees who shift from TM to MA when MA grows are likely *cheaper* than the average TM enrollee but *costlier* than the average MA enrollee, so *both* groups likely get more costly as MA grows."
10.10.2025 14:07 β π 0 π 0 π¬ 0 π 0
To be clear, the MA payment systemβs *existing* accuracy problems may (and, in my view, do) offer a strong rationale for reform. But the dynamics we consider here seem unlikely to do much, if anything, to bolster that case. /end
10.10.2025 13:57 β π 0 π 0 π¬ 1 π 0
A second is that rising MA penetration is unlikely to change selection patterns in ways that seriously reduce the accuracy of the MA payment system and necessitate reforms that would break the link between MA payments and TM costs.
10.10.2025 13:57 β π 0 π 0 π¬ 1 π 0
If thatβs right, it has a couple of implications. One is that TM is likely at little risk of entering a βdeath spiralβ in which higher MA penetration leads to greater favorable selection that induces still further increases in MA penetration, and so on.
10.10.2025 13:57 β π 0 π 0 π¬ 1 π 0
Our approach has limitations, including that it cannot address potential confounding from county differences that vary over time. But these results suggest that further growth in MA will have little effect on the degree of favorable selection into the program.
10.10.2025 13:57 β π 0 π 0 π¬ 1 π 0
For example, the results imply that if TMβs market share fell by 50%, then the effect on the TM-MA difference in risk-adjusted costs would lie somewhere between a negligible change and a decline of around 0.6 percentage points.
10.10.2025 13:57 β π 0 π 0 π¬ 1 π 0
Details are in the paper, but this figure shows the main results: across a wide range of assumptions about who βswitchersβ are (reflected in the different values of theta), changes in MA penetration have little effect on the degree of favorable selection into MA.
10.10.2025 13:57 β π 0 π 0 π¬ 1 π 0
The panel data allow us to control for persistent cross-county differences, while the model structure allows us to explicitly account for the fact that stayer-switcher cost differences may not coincide with differences in average costs between TM and MA enrollees.
10.10.2025 13:57 β π 0 π 0 π¬ 1 π 0
To address these issues, we use county-year panel data on MA penetration and stayer-switcher differences to estimate an empirical version of the theoretical model sketched above.
10.10.2025 13:57 β π 0 π 0 π¬ 1 π 0
Under this assumption, the model sketched above suggests that stayer-switcher cost differences may shrink as MA grows even if the difference in average costs between TM and MA enrollees is stable or growing. See, in particular, panels A and B below.
10.10.2025 13:57 β π 0 π 0 π¬ 1 π 0
This matters because MA penetration may not affect the two differences in the same way. To see why, suppose we make the (arguably fairly plausible) assumption that TM-to-MA βswitchersβ correspond to the enrollees on the margin between TM and MA.
10.10.2025 13:57 β π 0 π 0 π¬ 1 π 0
The second issue is more subtle. TM-to-MA βswitchersβ are likely not representative of MA enrollees as a whole, so the cost difference between stayers and switchers may not measure what weβre actually interested in: the difference in the *average* cost of TM and MA enrollees.
10.10.2025 13:57 β π 0 π 0 π¬ 1 π 0
Indeed, itβs notable that *changes* in MA penetration are associated with modest declines in stayer-switcher differences, consistent with the concern that cross-sectional relationships are confounded to some degree.
10.10.2025 13:57 β π 0 π 0 π¬ 1 π 0
The first is the potential for confounding. Counties with higher MA penetration may differ in other ways that affect stayer-switcher differences, masking the true causal relationship between MA penetration and stayer-switcher differences.
10.10.2025 13:57 β π 0 π 0 π¬ 1 π 0
But for a couple of reasons, this may not be a good guide to the causal effect of MA penetration on the degree of favorable selection into MA. There are two main issues.
10.10.2025 13:57 β π 0 π 0 π¬ 1 π 0
Prior work has examined the cross-sectional relationship between MA penetration and stayer-switcher differences in risk-adjusted costs, finding little relationship. We replicate that finding:
10.10.2025 13:57 β π 0 π 0 π¬ 1 π 0
If βswitchersβ have lower prior year spending than βstayersβ (after risk adjustment), thatβs indicative of favorable selection into MA. Larger stayer-switcher differences suggest more intense selection.
10.10.2025 13:57 β π 0 π 0 π¬ 1 π 0
Thus, we tackle this question empirically. To do so, we first construct a measure of favorable selection at the county-year level. Following prior work, our measure is the difference in the prior-year spending between TM-to-MA βswitchersβ and TM βstayers.β
10.10.2025 13:57 β π 0 π 0 π¬ 1 π 0
As illustrated in the figure below, the *gap* between the average cost of MA and TM enrollees can either grow or shrink as MA gets larger, depending on the exact shape of the relationship between beneficiary cost and propensity to enroll in MA vs. TM.
10.10.2025 13:57 β π 0 π 0 π¬ 1 π 0
Executive Director @taxlawcenter.org
Tax, law, policy, budget, economy. US & NZ.
Former Senior Director for Economic Policy @centeronbudget.bsky.social.
Personal account. Personal views. Frank G. Millard Professor of Law, University of Michigan Law School & Arlene Susan Kohn Professor of Social Policy, University of Michigan Ford School of Public Policy. Former General Counsel, HHS and OMB.
Healthcare services, tech & policy nerd. Alum: @theNAMedicine, @StanfordEng, @SAISHopkins, @CMCnews, @BCG and various health services & tech cos. https://dponeill.com/
Director of government affairs at HealthSherpa. ACA nerd. She/her, views my own.
Economics Professor at Brown, studying discrimination, education, healthcare, and applied econometrics. I like IV
https://sites.google.com/site/aboutpeterhull/home
Austrian π¦πΉ
Economist π
Not an Austrian Economist
Allen & Kelli Questrom Professor
BU Questrom, NBER, ECGI & NBER
https://florianederer.github.io/
VP for Health Policy at the Center on Budget and Policy Priorities. DSM native and @WSJ alumna. Views expressed here are mine. she/her
Health care reporter for NYTimes β following money and misdeeds in medicine. Very fond of dogs, old movies and mysteries. Give me a shout at abelson@nytimes.com.
Medicare expert. Deputy Director, Program on Medicare Policy @KFF. Part D, prescription drug policy, Medicare spending & financing, cyclist, NYT spelling bee fanatic.
Professor NYU Stern: former Obama CEA Senior Economist for tech & innovation; research on AI, robots, entrepreneurship, strategy
Associate Professor of Finance, NYU Stern
Newsletter: arpitrage.substack.com
Website: arpitgupta.info
Fellow | Economic Studies | @brookings.edu
Associate Director | @hamiltonproject.org
Board | @mazonusa.bsky.social
www.hamiltonproject.org
laurenhlb.01
Senior Fellow in Economic Studies at Brookings. Previously, director of The Hamilton Project at Brookings and before that chief economist of CBO.
Director, Hutchins Center on Fiscal & Monetary Policy, Brookings Institution
https://www.brookings.edu/people/david-wessel/
Senior Fellow and Director, Retirement Security Project @Brookings. Previously: Research Associate @NBER, Senior Fellow @SIEPR, Biden-Harris Council of Economic Advisers. Passionate about connecting research to policy.
https://www.gopishahgoda.org
Co-Chair, Arnold Ventures
health economist, climber, biker, looking for my #econtwitter, #econsky, #surgtweets, #healthpolicyvalentines communities
Institute Fellow at the Urban Institute Health Policy Center. A health economist who studies the ACA, Medicare, Medicaid and physician payment.